RSC
ABT icon

Red Spruce Capital’s Abbott ABT Stock Holding History

Red Spruce Capital’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29M Buy
36,210
+7,078
+24% +$646K 1.15% 31
2026
Q1 		$2.99M Buy
29,132
+1,406
+5% +$159K 1.23% 29
2025
Q4 		$3.47M Sell
27,726
-362
-1% -$46.1K 1.38% 26
2025
Q3 		$3.76M Sell
28,088
-313
-1% -$41.1K 1.53% 20
2025
Q2 		$3.86M Sell
28,401
-5,403
-16% -$712K 1.67% 17
2025
Q1 		$4.48M Sell
33,804
-828
-2% -$105K 2.11% 11
2024
Q4 		$3.92M Buy
34,632
+1,339
+4% +$155K 1.74% 16
2024
Q3 		$3.8M Buy
33,293
+578
+2% +$63.4K 1.73% 16
2024
Q2 		$3.4M Buy
32,715
+1,311
+4% +$139K 1.58% 19
2024
Q1 		$3.57M Buy
31,404
+2,388
+8% +$274K 1.66% 18
2023
Q4 		$3.19M Buy
29,016
+3,812
+15% +$381K 1.64% 19
2023
Q3 		$2.44M Buy
25,204
+41
+0.2% +$4.31K 1.39% 21
2023
Q2 		$2.74M Buy
25,163
+225
+0.9% +$24K 1.48% 18
2023
Q1 		$2.53M Buy
24,938
+1,423
+6% +$150K 1.48% 19
2022
Q4 		$2.58M Buy
23,515
+771
+3% +$79.8K 1.64% 20
2022
Q3 		$2.2M Buy
22,744
+914
+4% +$97.4K 1.54% 19
2022
Q2 		$2.37M Sell
21,830
-98
-0.4% -$11.1K 1.58% 16
2022
Q1 		$2.6M Buy
21,928
+823
+4% +$102K 1.47% 20
2021
Q4 		$2.97M Buy
21,105
+172
+0.8% +$22K 1.62% 19
2021
Q3 		$2.47M Buy
20,933
+408
+2% +$50.1K 1.45% 21
2021
Q2 		$2.38M Buy
20,525
+359
+2% +$41.9K 1.4% 22
2021
Q1 		$2.42M Buy
20,166
+604
+3% +$71.6K 1.54% 19
2020
Q4 		$2.14M Sell
19,562
-1,851
-9% -$201K 1.49% 23
2020
Q3 		$2.33M Sell
21,413
-35
-0.2% -$3.55K 1.89% 13
2020
Q2 		$1.96M Buy
21,448
+243
+1% +$22K 1.66% 19
2020
Q1 		$1.67M Sell
21,205
-32
-0.2% -$2.67K 1.74% 15
2019
Q4 		$1.84M Buy
+21,237
New +$1.78M 1.54% 19

Other funds holding ABT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Red Spruce Capital's ABT Position: Q2 2026 in Review

Red Spruce Capital increased its Abbott (ABT) stake by 24% in Q2 2026, buying an estimated $646K and bringing the position to 36,210 shares worth $3.29M. The position accounts for 1.15% of the portfolio, ranked #31.

Red Spruce Capital first reported a position in ABT in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.48M in Q1 2025. 684 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Red Spruce Capital held 36,210 shares of Abbott worth $3.29M as of Q2 2026.
  • Red Spruce Capital bought 7,078 Abbott shares in Q2 2026, an estimated $646K.
  • Abbott made up 1.15% of Red Spruce Capital's portfolio in Q2 2026, its #31 holding.
  • Red Spruce Capital first reported a position in Abbott in Q4 2019 and has held it in 27 quarters since.
  • Red Spruce Capital's Abbott position peaked at $4.48M in Q1 2025.
  • 684 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Red Spruce Capital's 13F filing for Q2 2026, filed 7 Jul 2026.